🎙️ GLP-1 Medications Explained: The $200 Billion Healthcare Revolution | OON Episode 19

The U.S. healthcare system is broken, and GLP-1 medications have become both a miracle and a mess. In this episode of Out of Network, Dr. Ryon Parker and Dr. Rishi Seth unpack the explosive world of semaglutide, tirzepatide, and the chaos surrounding these game-changing drugs.

What You'll Learn in This Video:
Why GLP-1s are projected to become a $200 billion market by 2029
The dangerous difference between med spa injections and proper medical supervision
Which GLP-1 medication actually works better (spoiler: it's not Ozempic)
Real strategies for patients who plateau or don't respond to treatment
Insurance coverage realities and what the new Medicare pricing means

Timestamps:
00:00 – Introduction: The $200 billion GLP-1 economy
03:15 – Wild West prescribing: Med spas vs. proper clinics
10:42 – Patient screening and medical supervision protocols
24:30 – Insurance coverage and pricing breakdown
32:00 – Tirzepatide vs. Semaglutide comparison
42:55 – Future predictions and closing thoughts

Connect with Out of Network:
🌐 Website: https://www.outofnetworkpod.com/
📱 Instagram:   / outofnetworkpodcast  
▶️ YouTube:    / @outofnetworkpodcast  
🎵 TikTok:   / outofnetworkpodcast  

Connect with the Hosts:
Dr. Ryon Parker →   / dr.ryonparker  
Parker Medical: https://parkermedical.org/
Dr. Rishi Seth →   / drrishiseth  
Seth Premiere Medical: https://sethmedical.com/

Enjoyed the Episode?
If this conversation resonated with you, please like, comment, and subscribe. Share it with someone who cares about the future of healthcare.

🎙 About Out of Network
Out of Network is a bold, physician-led podcast hosted by Dr. Ryon Parker and Dr. Rishi Seth. Each week, they challenge the broken healthcare system and explore how medicine can be reimagined—through patient-first care, prevention, and real human stories.

#outofnetworkPodcast #glp1 #ozempic #mounjaro #weightloss #healthcare #brokenhealthcare #conciergemedicine #medicaltruths #semaglutide #tirzepatide